Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Connor MP, Loren AW, Hexner EO, Martin ME, Gill SI, Luger SM, Mangan JK, Perl AE, McCurdy SR, Pratz KW, Timlin C, Freyer CW, Carulli A, Catania C, Smith J, Hollander L, Zebrowski AM, Stadtmauer EA, Porter DL, Frey NV.
Connor MP, et al. Among authors: pratz kw.
Transplant Cell Ther. 2023 Feb;29(2):113-118. doi: 10.1016/j.jtct.2022.10.027. Epub 2022 Nov 4.
Transplant Cell Ther. 2023.
PMID: 36336258
Free article.